{
  "DOI": "10.1038/ejhg.2011.276",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2011.276",
  "alternative-id": [
    "BFejhg2011276"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Xiefeng",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Lili",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Yanjie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shi",
      "given": "Zhumei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Yingyi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Junxia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Xirui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cao",
      "given": "Lei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Luo",
      "given": "Hui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Jiawei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Ning",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yin",
      "given": "Yongmei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "You",
      "given": "Yongping",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        1,
        25
      ]
    ],
    "date-time": "2012-01-25T23:17:47Z",
    "timestamp": 1327533467000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:04:42Z",
    "timestamp": 1684429482000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        26
      ]
    ],
    "date-time": "2024-02-26T17:29:15Z",
    "timestamp": 1708968555577
  },
  "is-referenced-by-count": 21,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2012,
        1,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2012,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            1,
            25
          ]
        ],
        "date-time": "2012-01-25T00:00:00Z",
        "timestamp": 1327449600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2011276.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2011276",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2011276.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "790-795",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2012,
        1,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        1,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nrc1476",
      "author": "PD Pharoah",
      "doi-asserted-by": "publisher",
      "first-page": "850",
      "journal-title": "Nat Rev",
      "key": "BFejhg2011276_CR1",
      "unstructured": "Pharoah PD, Dunning AM, Ponder BA, Easton DF : Association studies for finding cancer-susceptibility genetic variants. Nat Rev 2004; 4: 850–860.",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1007/978-90-481-3471-7_16",
      "author": "C Mondello",
      "doi-asserted-by": "publisher",
      "first-page": "307",
      "journal-title": "Subcell Biochem",
      "key": "BFejhg2011276_CR2",
      "unstructured": "Mondello C, Scovassi AI : Apoptosis: a way to maintain healthy individuals. Subcell Biochem 2010; 50: 307–323.",
      "volume": "50",
      "year": "2010"
    },
    {
      "DOI": "10.1038/24055",
      "author": "M Raff",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "journal-title": "Nature",
      "key": "BFejhg2011276_CR3",
      "unstructured": "Raff M : Cell suicide for beginners. Nature 1998; 396: 119–122.",
      "volume": "396",
      "year": "1998"
    },
    {
      "DOI": "10.1196/annals.1299.001",
      "author": "S Delhalle",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Ann NY Acad Sci",
      "key": "BFejhg2011276_CR4",
      "unstructured": "Delhalle S, Duvoix A, Schnekenburger M, Morceau F, Dicato M, Diederich M : An introduction to the molecular mechanisms of apoptosis. Ann NY Acad Sci 2003; 1010: 1–8.",
      "volume": "1010",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.onc.1207107",
      "author": "A Degterev",
      "doi-asserted-by": "publisher",
      "first-page": "8543",
      "journal-title": "Oncogene",
      "key": "BFejhg2011276_CR5",
      "unstructured": "Degterev A, Boyce M, Yuan J : A decade of caspases. Oncogene 2003; 22: 8543–8567.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1023/B:APPT.0000045786.98031.1d",
      "author": "KM Hajra",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Apoptosis",
      "key": "BFejhg2011276_CR6",
      "unstructured": "Hajra KM, Liu JR : Apoptosome dysfunction in human cancer. Apoptosis 2004; 9: 691–704.",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nm0897-917",
      "author": "G Ambrosini",
      "doi-asserted-by": "publisher",
      "first-page": "917",
      "journal-title": "Nat Med",
      "key": "BFejhg2011276_CR7",
      "unstructured": "Ambrosini G, Adida C, Altieri DC : A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921.",
      "volume": "3",
      "year": "1997"
    },
    {
      "DOI": "10.1038/25141",
      "author": "F Li",
      "doi-asserted-by": "publisher",
      "first-page": "580",
      "journal-title": "Nature",
      "key": "BFejhg2011276_CR8",
      "unstructured": "Li F, Ambrosini G, Chu EY et al: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580–584.",
      "volume": "396",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S1471-4914(01)02243-2",
      "author": "DC Altieri",
      "doi-asserted-by": "publisher",
      "first-page": "542",
      "journal-title": "Trends Mol Med",
      "key": "BFejhg2011276_CR9",
      "unstructured": "Altieri DC : The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542–547.",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1038/nrc2293",
      "author": "DC Altieri",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "Nat Rev Cancer",
      "key": "BFejhg2011276_CR10",
      "unstructured": "Altieri DC : Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61–70.",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1074/jbc.273.18.11177",
      "author": "G Ambrosini",
      "doi-asserted-by": "publisher",
      "first-page": "11177",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2011276_CR11",
      "unstructured": "Ambrosini G, Adida C, Sirugo G, Altieri DC : Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998; 273: 11177–11182.",
      "volume": "273",
      "year": "1998"
    },
    {
      "DOI": "10.1089/dna.2004.23.527",
      "author": "Y Xu",
      "doi-asserted-by": "publisher",
      "first-page": "527",
      "journal-title": "DNA Cell Biol",
      "key": "BFejhg2011276_CR12",
      "unstructured": "Xu Y, Fang F, Ludewig G, Jones G, Jones D : A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 2004; 23: 527–537.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.lungcan.2007.09.008",
      "author": "JS Jang",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Lung Cancer",
      "key": "BFejhg2011276_CR13",
      "unstructured": "Jang JS, Kim KM, Kang KH et al: Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 2008; 60: 31–39.",
      "volume": "60",
      "year": "2008"
    },
    {
      "DOI": "10.1136/jcp.2006.037804",
      "author": "AA Borbely",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "J Clin Pathol",
      "key": "BFejhg2011276_CR14",
      "unstructured": "Borbely AA, Murvai M, Szarka K et al: Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 2007; 60: 303–306.",
      "volume": "60",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ijc.25850",
      "author": "N Kawata",
      "doi-asserted-by": "publisher",
      "first-page": "1872",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2011276_CR15",
      "unstructured": "Kawata N, Tsuchiya N, Horikawa Y et al: Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer 2010; 129: 1872–1880.",
      "volume": "129",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10238-010-0122-5",
      "author": "BD Borges",
      "doi-asserted-by": "publisher",
      "first-page": "189",
      "journal-title": "Clin Exp Med",
      "key": "BFejhg2011276_CR16",
      "unstructured": "Borges BD, Burbano RR, Harada ML : Survivin −31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med 2011; 11: 189–193.",
      "volume": "11",
      "year": "2011"
    },
    {
      "DOI": "10.1097/MPA.0b013e3181d705d4",
      "author": "GE Theodoropoulos",
      "doi-asserted-by": "publisher",
      "first-page": "976",
      "journal-title": "Pancreas",
      "key": "BFejhg2011276_CR17",
      "unstructured": "Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M : Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 2010; 39: 976–980.",
      "volume": "39",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.urology.2008.09.048",
      "author": "YH Wang",
      "doi-asserted-by": "publisher",
      "first-page": "670",
      "journal-title": "Urology",
      "key": "BFejhg2011276_CR18",
      "unstructured": "Wang YH, Chiou HY, Lin CT et al: Association between survivin gene promoter −31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 2009; 73: 670–674.",
      "volume": "73",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s00384-008-0601-2",
      "author": "M Gazouli",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "Int J Colorectal Dis",
      "key": "BFejhg2011276_CR19",
      "unstructured": "Gazouli M, Tzanakis N, Rallis G et al: Survivin −31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis 2009; 24: 145–150.",
      "volume": "24",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s00432-009-0575-7",
      "author": "X Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1341",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "BFejhg2011276_CR20",
      "unstructured": "Yang X, Xiong G, Chen X et al: Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2009; 135: 1341–1349.",
      "volume": "135",
      "year": "2009"
    },
    {
      "DOI": "10.1245/s10434-010-1371-y",
      "author": "R Upadhyay",
      "doi-asserted-by": "publisher",
      "first-page": "880",
      "journal-title": "Ann Surg Oncol",
      "key": "BFejhg2011276_CR21",
      "unstructured": "Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B : Role of survivin gene promoter polymorphism (−31G\u0026gt;C) in susceptibility and survival of esophageal cancer in Northern India. Ann Surg Oncol 2011; 18: 880–887.",
      "volume": "18",
      "year": "2011"
    },
    {
      "author": "ZJ Cheng",
      "first-page": "258",
      "journal-title": "Ai Zheng",
      "key": "BFejhg2011276_CR22",
      "unstructured": "Cheng ZJ, Hu LH, Huang SJ : [Correlation of −31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma]. Ai Zheng 2008; 27: 258–263.",
      "volume": "27",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10620-008-0441-5",
      "author": "L Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1021",
      "journal-title": "Dig Dis Sci",
      "key": "BFejhg2011276_CR23",
      "unstructured": "Yang L, Zhu H, Zhou B et al: The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 2009; 54: 1021–1028.",
      "volume": "54",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.canep.2011.01.004",
      "author": "S Bayram",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "journal-title": "Cancer Epidemiol",
      "key": "BFejhg2011276_CR24",
      "unstructured": "Bayram S, Akkiz H, Bekar A, Akgollu E : The association between the survivin −31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Cancer Epidemiol 2011; 35: 555–559.",
      "volume": "35",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0016748",
      "author": "F Ma",
      "doi-asserted-by": "publisher",
      "first-page": "e16748",
      "journal-title": "PLoS One",
      "key": "BFejhg2011276_CR25",
      "unstructured": "Ma F, Zhang H, Zhai Y et al: Functional polymorphism −31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among Chinese. PLoS One 2011; 6: e16748.",
      "volume": "6",
      "year": "2011"
    },
    {
      "author": "N Mantel",
      "first-page": "719",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2011276_CR26",
      "unstructured": "Mantel N, Haenszel W : Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748.",
      "volume": "22",
      "year": "1959"
    },
    {
      "DOI": "10.1016/0197-2456(86)90046-2",
      "author": "R DerSimonian",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Control Clin Trials",
      "key": "BFejhg2011276_CR27",
      "unstructured": "DerSimonian R, Laird N : Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.",
      "volume": "7",
      "year": "1986"
    },
    {
      "author": "YH Wang",
      "first-page": "1331",
      "journal-title": "Saudi Med J",
      "key": "BFejhg2011276_CR28",
      "unstructured": "Wang YH, Chen DJ, Yi TN, Liu XH : The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue. Saudi Med J 2010; 31: 1331–1336.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1074/jbc.M110.152777",
      "author": "H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "36129",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2011276_CR29",
      "unstructured": "Wang H, Holloway MP, Ma L et al: Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. J Biol Chem 2010; 285: 36129–36137.",
      "volume": "285",
      "year": "2010"
    },
    {
      "DOI": "10.3892/ijo_00000464",
      "author": "E Krepela",
      "doi-asserted-by": "publisher",
      "first-page": "1449",
      "journal-title": "Int J Oncol",
      "key": "BFejhg2011276_CR30",
      "unstructured": "Krepela E, Dankova P, Moravcikova E et al: Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol 2009; 35: 1449–1462.",
      "volume": "35",
      "year": "2009"
    },
    {
      "author": "L Farnebo",
      "first-page": "453",
      "journal-title": "Oncol Rep",
      "key": "BFejhg2011276_CR31",
      "unstructured": "Farnebo L, Jerhammar F, Vainikka L, Grenman R, Norberg-Spaak L, Roberg K : Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines. Oncol Rep 2008; 20: 453–461.",
      "volume": "20",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.leukres.2007.11.013",
      "author": "M Wagner",
      "doi-asserted-by": "publisher",
      "first-page": "1054",
      "journal-title": "Leuk Res",
      "key": "BFejhg2011276_CR32",
      "unstructured": "Wagner M, Schmelz K, Dorken B, Tamm I : Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia. Leuk Res 2008; 32: 1054–1060.",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.1002/gcc.20533",
      "author": "R Boidot",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "BFejhg2011276_CR33",
      "unstructured": "Boidot R, Vegran F, Jacob D et al: The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas. Genes Chromosomes Cancer 2008; 47: 299–308.",
      "volume": "47",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.onc.1209784",
      "author": "F Vegran",
      "doi-asserted-by": "publisher",
      "first-page": "290",
      "journal-title": "Oncogene",
      "key": "BFejhg2011276_CR34",
      "unstructured": "Vegran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S : Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 2007; 26: 290–297.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1002/mc.20181",
      "author": "HS Floyd",
      "doi-asserted-by": "publisher",
      "first-page": "506",
      "journal-title": "Mol Carcinog",
      "key": "BFejhg2011276_CR35",
      "unstructured": "Floyd HS, Jennings-Gee JE, Kock ND, Miller MS : Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice. Mol Carcinog 2006; 45: 506–517.",
      "volume": "45",
      "year": "2006"
    },
    {
      "author": "J Nakano",
      "first-page": "1215",
      "journal-title": "Int J Oncol",
      "key": "BFejhg2011276_CR36",
      "unstructured": "Nakano J, Huang CL, Liu D, Ueno M, Sumitomo S, Yokomise H : Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Int J Oncol 2005; 27: 1215–1221.",
      "volume": "27",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-1187",
      "author": "JM Teodoridis",
      "doi-asserted-by": "publisher",
      "first-page": "8961",
      "journal-title": "Cancer Res",
      "key": "BFejhg2011276_CR37",
      "unstructured": "Teodoridis JM, Hall J, Marsh S et al: CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res 2005; 65: 8961–8967.",
      "volume": "65",
      "year": "2005"
    },
    {
      "author": "M Kimura",
      "first-page": "1",
      "journal-title": "Gan To Kagaku Ryoho",
      "key": "BFejhg2011276_CR38",
      "unstructured": "Kimura M, Okano Y : [Aurora kinases and cancer]. Gan To Kagaku Ryoho 2005; 32: 1–5.",
      "volume": "32",
      "year": "2005"
    },
    {
      "author": "Y Saitoh",
      "first-page": "137",
      "journal-title": "Int J Oncol",
      "key": "BFejhg2011276_CR39",
      "unstructured": "Saitoh Y, Yaginuma Y, Ishikawa M : Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol 1999; 15: 137–141.",
      "volume": "15",
      "year": "1999"
    },
    {
      "DOI": "10.1038/onc.2009.525",
      "author": "R Boidot",
      "doi-asserted-by": "publisher",
      "first-page": "2577",
      "journal-title": "Oncogene",
      "key": "BFejhg2011276_CR40",
      "unstructured": "Boidot R, Vegran F, Jacob D et al: The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene 2010; 29: 2577–2584.",
      "volume": "29",
      "year": "2010"
    },
    {
      "author": "L Farnebo",
      "first-page": "549",
      "journal-title": "Int J Mol Med",
      "key": "BFejhg2011276_CR41",
      "unstructured": "Farnebo L, Jedlinski A, Ansell A et al: Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines. Int J Mol Med 2009; 24: 549–556.",
      "volume": "24",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.radonc.2009.06.007",
      "author": "J Loof",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Radiother Oncol",
      "key": "BFejhg2011276_CR42",
      "unstructured": "Loof J, Pfeifer D, Adell G, Sun XF : Significance of an exon 2 G4C14-to-A4T14 polymorphism in the p73 gene on survival in rectal cancer patients with or without preoperative radiotherapy. Radiother Oncol 2009; 92: 215–220.",
      "volume": "92",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1442-2050.2008.00885.x",
      "author": "X Yang",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Dis Esophagus",
      "key": "BFejhg2011276_CR43",
      "unstructured": "Yang X, Xiong G, Chen X et al: Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism. Dis Esophagus 2009; 22: 223–230.",
      "volume": "22",
      "year": "2009"
    },
    {
      "author": "CH Han",
      "first-page": "289",
      "journal-title": "Int J Clin Exp Med",
      "key": "BFejhg2011276_CR44",
      "unstructured": "Han CH, Wei Q, Lu KK, Liu Z, Mills GB, Wang LE : Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med 2009; 2: 289–299.",
      "volume": "2",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.canlet.2006.12.020",
      "author": "MJ Duffy",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Cancer Lett",
      "key": "BFejhg2011276_CR45",
      "unstructured": "Duffy MJ, O’Donovan N, Brennan DJ, Gallagher WM, Ryan BM : Survivin: a promising tumor biomarker. Cancer Lett 2007; 249: 49–60.",
      "volume": "249",
      "year": "2007"
    },
    {
      "DOI": "10.1007/978-1-4020-6554-5_4",
      "author": "A Melet",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "journal-title": "Adv Exp Med Biol",
      "key": "BFejhg2011276_CR46",
      "unstructured": "Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R : Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 2008; 615: 47–79.",
      "volume": "615",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-05-0375",
      "author": "S Fukuda",
      "doi-asserted-by": "publisher",
      "first-page": "1087",
      "journal-title": "Mol Cancer Ther",
      "key": "BFejhg2011276_CR47",
      "unstructured": "Fukuda S, Pelus LM : Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087–1098.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrc968",
      "author": "DC Altieri",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "journal-title": "Nat Rev Cancer",
      "key": "BFejhg2011276_CR48",
      "unstructured": "Altieri DC : Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46–54.",
      "volume": "3",
      "year": "2003"
    },
    {
      "DOI": "10.1172/JCI14123",
      "author": "JC Reed",
      "doi-asserted-by": "publisher",
      "first-page": "965",
      "journal-title": "J Clin Invest",
      "key": "BFejhg2011276_CR49",
      "unstructured": "Reed JC : The Survivin saga goes in vivo. J Clin Invest 2001; 108: 965–969.",
      "volume": "108",
      "year": "2001"
    },
    {
      "author": "I Tamm",
      "first-page": "5315",
      "journal-title": "Cancer Res",
      "key": "BFejhg2011276_CR50",
      "unstructured": "Tamm I, Wang Y, Sausville E et al: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315–5320.",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1021/bi001603q",
      "author": "S Shin",
      "doi-asserted-by": "publisher",
      "first-page": "1117",
      "journal-title": "Biochemistry",
      "key": "BFejhg2011276_CR51",
      "unstructured": "Shin S, Sung BJ, Cho YS et al: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001; 40: 1117–1123.",
      "volume": "40",
      "year": "2001"
    },
    {
      "DOI": "10.1021/bi0485171",
      "author": "C Sun",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Biochemistry",
      "key": "BFejhg2011276_CR52",
      "unstructured": "Sun C, Nettesheim D, Liu Z, Olejniczak ET : Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry 2005; 44: 11–17.",
      "volume": "44",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.onc.1206978",
      "author": "T Liu",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "Oncogene",
      "key": "BFejhg2011276_CR53",
      "unstructured": "Liu T, Brouha B, Grossman D : Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004; 23: 39–48.",
      "volume": "23",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0140-6736(03)13910-4",
      "author": "PJ Kim",
      "doi-asserted-by": "publisher",
      "first-page": "205",
      "journal-title": "Lancet",
      "key": "BFejhg2011276_CR54",
      "unstructured": "Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC : Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003; 362: 205–209.",
      "volume": "362",
      "year": "2003"
    },
    {
      "DOI": "10.1074/jbc.M603414200",
      "author": "XH Peng",
      "doi-asserted-by": "publisher",
      "first-page": "25903",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2011276_CR55",
      "unstructured": "Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L : Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006; 281: 25903–25914.",
      "volume": "281",
      "year": "2006"
    },
    {
      "author": "F Li",
      "first-page": "3143",
      "journal-title": "Cancer Res",
      "key": "BFejhg2011276_CR56",
      "unstructured": "Li F, Altieri DC : The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 1999; 59: 3143–3151.",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0167-4781(00)00142-1",
      "author": "M Otaki",
      "doi-asserted-by": "publisher",
      "first-page": "188",
      "journal-title": "Biochim Biophys Acta",
      "key": "BFejhg2011276_CR57",
      "unstructured": "Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T : Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta 2000; 1493: 188–194.",
      "volume": "1493",
      "year": "2000"
    },
    {
      "DOI": "10.1097/00125817-200203000-00002",
      "author": "JN Hirschhorn",
      "doi-asserted-by": "publisher",
      "first-page": "45",
      "journal-title": "Genet Med",
      "key": "BFejhg2011276_CR58",
      "unstructured": "Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K : A comprehensive review of genetic association studies. Genet Med 2002; 4: 45–61.",
      "volume": "4",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.canlet.2009.05.005",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "journal-title": "Cancer Lett",
      "key": "BFejhg2011276_CR59",
      "unstructured": "Wang Y, Yang H, Li H et al: Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett 2009; 285: 134–140.",
      "volume": "285",
      "year": "2009"
    }
  ],
  "reference-count": 59,
  "references-count": 59,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2011276"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Association between survivin −31G\u0026gt;C promoter polymorphism and cancer risk: a meta-analysis"
  ],
  "type": "journal-article",
  "volume": "20"
}